Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Creative Biosciences (Guangzhou) Co., Ltd.
Guangzhou, Guangdong, China
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Creative Biosciences’ Colosafe is the first National Medical Products Administration (NMPA, China) approved stool DNA test for early detection of colorectal cancer. It demonstrates high sensitivity and specificity; ongoing development for additional noninvasive cancer screening kits.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic kitDevice
- Industry
- Molecular Diagnostics
02
Partnerships
Supported by multiple venture capital rounds and government support, but explicit industrial partnerships not listed
Beyond the preview
Go deeper on Creative Biosciences (Guangzhou) Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Creative Biosciences (Guangzhou) Co., Ltd..